
A SPAC III Acquisition Corp. (NASDAQ: ASPCU) relating to the proposed Merger with Bioserica International Limited 禾素國際有限公司. Pursuant to the terms of the Merger Agreement, relating to the proposed merger with Under pursuant to the terms of the Merger Agreement, the aggregate consideration to be paid to existing shareholders and holders of equity awards of Bioserica is $200,000,000, which will be paid entirely in stock, comprised of newly issued Class B Ordinary Shares of the Purchaser at a price of $10.00 per share.